|
Originally published In Press as doi:10.1074/jbc.M207184200 on August 21, 2002
J. Biol. Chem., Vol. 277, Issue 43, 40729-40734, October 25, 2002
An ATP-binding Cassette Transporter Is a Major Glycoprotein of
Sea Urchin Sperm Membranes*
Kathryn J.
Mengerink and
Victor D.
Vacquier
From the Center for Marine Biotechnology and Biomedicine, Scripps
Institution of Oceanography, University of California San Diego, La
Jolla, California 92093-0202
Received for publication, July 18, 2002, and in revised form, August 8, 2002
 |
ABSTRACT |
Sperm are terminally differentiated cells that
undergo several membrane-altering events before fusion with eggs. One
event, the sea urchin sperm acrosome reaction (AR), is blocked by the lectin wheat germ agglutinin (WGA). In an effort to identify proteins involved in the AR induction, the peptide sequence was obtained from a
220-kDa WGA-binding protein. Degenerate PCR and library screening
resulted in the full-length deduced amino acid sequence of an
ATP-binding cassette transporter, suABCA. The protein of 1,764 residues
has two transmembrane regions, two nucleotide-binding domains, and is
most closely related to the human ABC subfamily A member 3 transporter
(ABCA3). Sequence analysis suggests a large extracellular loop between
transmembrane spanning segments 7 and 8, with five
N-linked glycosylation sites. An antibody made to the loop
region binds to non-permeabilized cells, supporting that this region is
extracellular. suABCA is found in sperm membrane vesicles, it can be
solubilized with nonionic detergents, and it shifts from 220 to 200 kDa
upon protein:N-glycanase F digestion. suABCA localizes to
the entire surface of sperm in a punctate pattern, but is not detected
in lipid rafts. Based on its relationship to subfamily A, suABCA is
most likely involved in phospholipid or cholesterol transport. This is
the first investigation of an ABC transporter in animal sperm.
 |
INTRODUCTION |
As spermatocytes mature, their shape is altered from round,
undifferentiated spermatocytes to long, thin, highly compartmentalized, terminally differentiated cells. Most sperm consist of a head containing an acrosomal vesicle and a nucleus, a midpiece containing mitochondria, and a long flagellum. Upon release into seawater, sea
urchin sperm activate motility and, before fusing with eggs, undergo
the exocytotic acrosome reaction
(AR).1 In mammals, this
process is further complicated by the need to undergo capacitation
before the AR can be triggered. Capacitation is a poorly understood
process involving cholesterol efflux, changes in intracellular ion
concentrations, and tyrosine phosphorylation (1). All of these
processes involve changes in membrane structure and composition (2),
and the molecules involved in these changes are only now being discovered.
One of the best studied membrane-altering events in fertilization is
the sea urchin sperm AR. When sperm contact a fucose sulfate polymer
contained in the jelly layer surrounding the egg, multiple fusions
occur between the acrosomal vesicle and the plasma membrane of sperm
resulting in exocytosis of the vesicle (3). A newly exposed membrane,
covering the actin-containing acrosomal process, then fuses with the
egg plasma membrane (4). Wheat germ agglutinin (WGA) blocks the egg
jelly-induced AR of sea urchin sperm (5). One WGA-binding protein,
suREJ1, has been demonstrated to be involved in triggering the AR (6),
and another, suREJ3, has been implicated in this process (7). This
paper identifies another major WGA-binding protein of sea urchin sperm
as an ATP-binding cassette (ABC) transporter, most closely related to
human ABCA3.
ABC transporters make up one of the largest families of transmembrane
proteins and have been identified in every organism. These proteins use
ATP to drive the transport of a wide variety of substances across the
membrane including phospholipids, amino acids, peptides, toxins,
metals, and antibiotics. The functional unit contains two distinct
transmembrane regions, each with five to eight transmembrane spanning
segments (TMS), and two distinct nucleotide-binding domains (NBDs). In
bacteria, each domain is a separate polypeptide, whereas in eukaryotes
a single polypeptide chain can contain a half-transporter (one
transmembrane region and one NBD) or a full transporter with two
transmembrane regions and two NBDs (8, 9).
Forty-eight human ABC transporters are divided into seven distinct
families based on sequence similarity. Human subfamily A contains 12 members, which can be further subdivided into two distinct groups (10).
The first group in subfamily A has seven members, all of which are
implicated in phospholipid and cholesterol transport. Here we identify
a sea urchin ABC transporter belonging to the subfamily A. This is the
first description of an ABC transporter in animal sperm.
 |
EXPERIMENTAL PROCEDURES |
Protein Preparation and Peptide Sequencing--
All procedures
were on ice or at 4 °C. Sea urchins, Strongylocentrotus
purpuratus, were spawned by injection with 0.5 M KCl and the undiluted sperm collected with a Pasteur pipette. Sperm were
resuspended in 0.45-µm filtered seawater (FSW), coelomocytes were
removed by three (5 min) centrifugations at 200 × g
and sperm cells sedimented at 5,000 × g (15 min).
Sperm membranes were solubilized by suspending sperm pellets in 0.15 M NaCl, 10 mM HEPES, pH 7.4, and 1% Nonidet
P-40. Solubilized protein was obtained from the supernatant after
centrifugation at 100,000 × g for 1 h. This supernatant was applied to a WGA-agarose column (EY Laboratories). The
column was washed with 50 column volumes of wash buffer (0.15 M NaCl, 10 mM HEPES, 0.1% Nonidet P-40, pH
7.4) and the protein eluted in wash buffer containing 100 mM N-acetyl-D-glucosamine. SDS-PAGE
was performed (11) and the gel stained with Coomassie Brilliant Blue.
The 220-kDa band was cut excised from the gel, destained, and sent to
the Stanford University PAN Facility for trypsin digestion and peptide sequencing.
DNA Sequencing and Sequence Analysis--
Degenerate primers
were designed according to peptides 1 and 3 and used to amplify a
message from cDNA from an entire sea urchin. Specific primers were
made to this message and 3' rapid amplification of cDNA ends
(Ambion) with testis mRNA was performed to obtain most of the 3'
end of the sequence. This product was used to screen a testis
ZAP II library (Stratagene). Overlapping clones were
obtained and sequenced.
suABCA homologs were identified using BLAST (12). Specific domains and
glycosylation sites were found using the ProfileScan website
(www.isrec.isb-sib.ch/software/PFSCAN_form.html) and the PredictProtein website
(dodo.cpmc.columbia.edu/predictprotein/predictprotein.html). The signal
sequence was predicted using the SignalP website (13). TMS were
predicted using hydropathy plots that were generated by the method of
Kyte and Doolittle with a window of 14 amino acids (14), as well as the
TMHMM website (www.cbs.dtu.dk/services/TMHMM-2.0/html; Ref. 15).
Multiple sequence alignments were made using Clustal W, Clustal X, and
GeneDoc (16-18). Neighbor joining trees with bootstrap values (1,000 replicas) were made using Clustal X and viewed using TreeView (19).
Antibody Production--
A portion of suABCA DNA corresponding
to Ala961-Pro1158 was ligated into the pET15b
vector (Novagen), which contains an NH2-terminal His tag,
and bacterially expressed according to a previously published protocol
(7). The resulting purified recombinant protein, ABCe, was separated by
SDS-PAGE and negatively stained with cupric chloride (20). The protein
was excised, destained, and used to make commercially raised anti-ABCe
rabbit antibodies (Strategic BioSolutions). The antibodies were
subsequently affinity purified on an ABCe-conjugated Affi-Gel-15 column
(Bio-Rad).
Other Methods--
Sperm membrane vesicles (SMVs) were made
according to the pH 9 method (21, 33). For
protein:N-glycosidase F (PNGase F) treatment of sperm
protein, 40 µg of WGA eluate containing 0.5% SDS and 50 mM -mercaptoethanol was boiled 5 min. Nonidet P-40 was
added to 7.5%, followed by 2.4 µl of PNGase F and 27.6 µl of
distilled water. The sample was incubated overnight at 37 °C. Following deglycosylation, the sample was separated on SDS-PAGE, transferred to PVDF, and Western blots performed using ABCe antibody. Lipid rafts were made following a previously described protocol (22).
Briefly, 200 µl of dry sperm were solubilized with 1 ml of 1% Triton
X-100 in solubilization buffer (SB; 10 mM Tris-HCl, pH 7.5, 0.15 M NaCl, 5 mM EDTA), incubated on ice for
20 min, and homogenized with 10 strokes of a Dounce homogenizer. The
cell debris was removed by a 5 min, 1,300 × g
centrifugation. The supernatant was mixed with equal volume of 85%
(w/v) sucrose in SB. Two milliliters of the resulting supernatant were
layered successively with 6 ml 30% sucrose in SB and 3.5 ml 5%
sucrose in SB. The lipid rafts were obtained by ultracentrifugation at
200,000 × g at 4 °C for 18 h, and 1-ml
fractions were collected. Protein was separated by SDS-PAGE, and gels
were stained with silver (23), Coomassie Brilliant Blue, or transferred
to PVDF for immunoblotting. Transfer to PVDF was in 20% methanol:80%
water with 192 mM glycine and 25 mM Tris-OH at
pH 8.3. Blots were blocked in 5% nonfat dry milk and incubated 1 h with a 1:20,000 dilution of primary antibody. After washing in 150 mM NaCl, the membranes were reacted 1 h with a
1:50,000 dilution of horseradish peroxidase-conjugated goat antirabbit
IgG (Calbiochem). Membranes were developed the SuperSignal West Dura
Extended Duration Substrate kit (Pierce).
Immunofluorescence--
Freshly spawned sperm were diluted 1:100
and incubated 10 min in FSW containing 3% paraformaldehyde and 0.1%
glutaraldehyde. Fixed cells were washed three times for 10 min with
PBS, pH 7.4. For washing, cells were sedimented by a 5 min
centrifugation at 1,000 × g and resuspended in PBS.
Permeabilized sperm were incubated 10 min in PBS containing 0.2%
Nonidet P-40 and then washed three times. Nonspecific sites were
blocked with 3% bovine serum albumin in PBS for 30 min and then
incubated for 1 h with primary antibody in blocking solution. This
was followed by three 10-min washes in PBS, a 1-h incubation in
Alexafluor 546 goat anti-rabbit IgG (Molecular Probes), and three
additional washes before viewing by epifluorescence. Control cells,
treated with only the second antibody, had absolutely no fluorescence.
 |
RESULTS |
Peptide Sequencing and Sequence Analysis--
Several high
molecular weight proteins are enriched in WGA eluates of solubilized
sperm protein when compared with the starting material, including
suREJ1 and suREJ3 (6, 7). The 220-kDa band is enriched in the eluate
and can also be detected in the starting material (Fig.
1). To purify this protein, a WGA-eluate was separated by SDS-PAGE and the gel stained with Coomassie Brilliant Blue. The 220-kDa protein was excised and trypsin digestion and peptide
sequencing performed. Three peptide sequences were obtained (Fig.
2). Peptides 1 and 3 were used to design
degenerate primers and the primers used to amplify a partial sequence
from cDNA. The initial PCR product was then used to obtain the
full-length sequence by a combination of screening a testis cDNA
library and 3' rapid amplification of cDNA ends with testis
cDNA. Using BLAST to search GenBankTM identified this
protein as a new member of the ABC transporter superfamily, named
suABCA.

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 1.
The 220-kDa protein was enriched by WGA
chromatography. The silver-stained gel of Nonidet P-40 solubilized
sperm proteins (N) and WGA-binding proteins (W)
is shown. Previously identified proteins are labeled to the
right in regular text, and the 220-kDa protein of the
current study is labeled in bold text. suRE3-N,
NH2-terminal portion; and suREJ3-C,
COOH-terminal portion of suREJ3 (7). The apparent molecular mass of
these proteins vary, depending on the type of SDS-PAGE performed. Thus,
the 220-kDa protein has been referred to as the 190-kDa protein and
suREJ1 as the 210-kDa protein in previously published articles (6, 31,
33, 35).
|
|

View larger version (77K):
[in this window]
[in a new window]
|
Fig. 2.
The deduced amino acid sequence of
suABCA. The gray boxes denote domains or regions
corresponding to peptide sequences, with names listed above. TMS are
labeled above the sequence and are in boldface and
italicized. Asterisks indicate potential
Asn-linked glycosylation sites. The region expressed to make the
antibody, ABCe, is underlined.
|
|
suABCA is a 1,764-amino acid full ABC transporter, containing two NBDs
and two transmembrane regions of six TMS each (Fig. 2). SignalP
predicts a signal sequence from Met1 to Arg44.
All three peptides were found in the deduced suABCA amino acid sequence. The NBDs of suABCA contain the subfamily A signature sequences, including the Walker A motif, the #50 sequence, the "hot
spot," the ATS/C region, the Walker B motif, and the Switch #162
sequence (Fig. 3A; Refs. 24
and 25). Within all of these regions, the two homologous domains of
suABCA vary by only three amino acids. Also, suABCA is conserved in the
additional ABCA regions 100-130 amino acids downstream of the
Walker B motif, varying by only two amino acids.

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 3.
The sea urchin ABC transporter belongs to
human subfamily A and is most closely related to member ABCA3.
A, alignments of suABCA with the subfamily A-specific NBD
sequence. Boldface amino acids are conserved in all ABC
transporters, and X indicates any amino acid. The top line
is the consensus sequence (con), and the second line is
suABCA (su). Dots denote identity. B,
Kyte-Doolittle hydrophilicity plots. The predicted TMS are numbered
underneath their respective peaks. The black bars indicate
two large extracellular loops, and the NBDs are shaded gray.
C, a neighbor joining tree showing the relationship of
suABCA to the human subfamily A group 1 members, based on multiple
sequence alignments spanning the entire length of all proteins.
Bootstrap values are at nodes. GenBankTM accession numbers
are as follows: hABCA1, AAD49849; hABCA2, Q9BZC7; hABCA3, XP_028843;
hABCA4, NP_000341; hABCA7, AAK00959; hABCA12,
AAK54355; suABCA, AF529424. D, a schematic diagram
demonstrates the predicted membrane topology and the location of the
three peptide sequences (boxed). Potential
N-linked sites are marked with an asterisk.
|
|
A Kyte-Doolittle plot (Fig. 3B) indicates that suABCA has 12 predicted TMS, with the first TMS located within the putative signal
sequence. The TMS are also predicted by TMHMM (15). Between TMS 1-2
and TMS 7-8 are large, putative extracellular loops of 158 and 242 residues, respectively. The first loop contains three potential
N-linked glycosylation sites, and five are predicted in the
second loop (Fig. 3D). Two of the peptide sequences are found in the second loop and each includes an N-linked
glycosylation site. In both cases, the asparagine could not be
determined by Edman degradation, most likely due to possession of
oligosaccharide chains.
The human ABC transporter subfamily A is divided into two
groups based on phylogeny (10). Human ABCA1, -2, -3, -4, -7, and -12 fall into one group. Multiple sequence alignments of suABCA to this
group show the sea urchin transporter to be most similar to member 3 (Fig. 3C). Also, suABCA is similar in size to human ABCA3
(1,764 compared with 1,704 amino acids) and, like human ABCA3, contains
a shorter extracellular loop between TMS 1 and 2 in comparison to the
other members of this group. In summary, suABCA has a large
glycosylated extracellular loop in the first transmembrane region and a
second larger glycosylated loop in the second transmembrane region. Six
TMS are predicted in each transmembrane region; however, TMS1 may be
cleaved after the signal sequence (Fig. 2).
Immunoblots--
Anti-ABCe antibody reacts with a band at the
expected size of 220 kDa in an Nonidet P-40 extract of whole sperm
(Fig. 4A). The antigen is
enriched in sperm membrane vesicles and is not present in the
supernatant of the vesicle preparation. A second band, appearing in the
SMV sample, is most likely a breakdown product. suABCA is highly
enriched in the WGA eluate. Lanes N, V, and
S contain 10 µg of protein, while lane W
contains 0.5 µg of protein. The density of the band in lane
W is similar to that of the SMV preparation, indicating that the
WGA eluate provides approximately a 20-fold enrichment of the suABCA
transporter. Based on amino acid sequence alone, suABCA should be
~195 kDa. Treatment of WGA-binding proteins with PNGase F, followed
by anti-ABCe immunoblotting, demonstrates that suABCA shifts in
relative mass from 220 to 200 kDa (Fig. 4B), confirming
N-linked glycosylation.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 4.
Immunoblots using anti-ABCe.
A: N, Nonidet P-40-solubilized sperm protein;
V, solubilized sperm membrane vesicles; S,
supernatant of sperm membrane vesicles; W, wheat germ
agglutinin eluate. N, V, and W, 10 µg per lane. W, 0.5 µg per lane.
B, PNGase F-treated solubilized sperm protein (+)
versus the untreated control ( ).
|
|
Localization of suABCA--
Immunofluorescence using the
anti-ABCe antibody localizes the antigen to the entire surface of sperm
in a punctate pattern (Fig.
5A). This pattern and level of
fluorescence was seen in both nonpermeabilized and permeabilized cells
and was not altered by time of fixation. Also, decreasing the
concentration of antibody resulted in the same punctate pattern with
lower levels of fluorescence. Cells reacted with only the secondary
antibody had absolutely no fluorescence. Because of the punctate
pattern and possible role of suABCA in phospholipid or cholesterol
transport, lipid rafts were isolated and tested for the presence of
suABCA (Fig. 5B). A sucrose cushion was floated
on top of the detergent-extracted supernatant and the sample
ultracentrifuged. This resulted in a lipid-dense band in fraction 4, which has been characterized previously as the glycosphingolipid-rich
raft fraction (22). Fractions taken from top to bottom show that suABCA
is mostly solubilized by detergent and is not detected in the lipid
raft fraction.

View larger version (67K):
[in this window]
[in a new window]
|
Fig. 5.
suABCA is present in a punctate pattern all
over sperm but is not detected in lipid rafts. A, phase
contrast image of sperm on the left and the same sperm on
the right showing immunofluorescence of anti-ABCe. In the
absence of primary antibody there was absolutely no fluorescence
associated with the cells. B, anti-ABCe immunoblot of
fractions taken from the sucrose gradient of the lipid raft experiment.
The first panel is a silver-stained gel, and the
second panel is the immunoblot. Fraction 4 contains the
lipid rafts; fractions 6, 8, and 10 are part of the sucrose gradient;
and fraction 12 is the solubilized sperm protein.
|
|
 |
DISCUSSION |
WGA blocks the egg jelly-induced AR of sea urchin sperm (5), and
there are ~10 major WGA-binding proteins visible on a silver-stained
gel. One or more of these proteins must play a role in AR induction.
suREJ1 was the first WGA-binding protein shown to be a receptor for the
egg jelly fucose sulfate polymer, a known AR inducer (3, 6). Also, the
NH2- and COOH-terminal halves of suREJ3 bind WGA and are
implicated in the AR, due to their location on the plasma membrane
covering the acrosomal vesicle (7).
The 220-kDa (previously reported as 190 kDa; Refs. 21 and 33)
WGA-binding protein was shown to be an ABC transporter belonging to the human subfamily A transporters. Twelve members of this subfamily
have been identified from human, which are all full transporters with
two transmembrane regions and two NBDs (25). Available data show that
the members of subfamily A are involved in cholesterol or phospholipid
transport (10). Members of subfamily A that cluster with suABCA
include ABCA1, -2, -3, -4, -7, and -12. suABCA is most similar to human
ABCA3 (Fig. 3C). ABCA3 is found associated with the lamellar
bodies of lung alveolar type II cells and is thought to play a role in
phospholipid transport during surfactant production (26, 27). The best
studied member of this subfamily is ABCA1, mutations in which cause the
autosomal recessive disorder Tangier disease. Patients with Tangier
disease have virtually no plasma high density lipoprotein (HDL), they accumulate cholesterol in macrophages, and they have a high incidence of atherosclerosis (28, 29). Accumulating evidence shows ABCA1 transports cholesterol and phospholipids to lipid-poor apolipoproteins, such as HDL (28, 29). It is tempting to speculate that suABCA has a
similar lipid-transporting function.
Transmission electron micrographs of filipin-cholesterol complexes show
that during capacitation, cholesterol increases over the guinea pig
acrosomal vesicle (2). During capacitation, mammalian sperm lose
cholesterol from their membranes. Bovine serum albumin, cyclodextrins,
and HDL are all capable of binding cholesterol and increasing the rate
of capacitation (1). In mammalian sperm, no mechanism has been
described for cholesterol removal from membranes. An ABCA transporter
would be an ideal protein to perform such a task. However, sea urchin
sperm no not appear to have a capacitation-like process and are capable
of acrosome reacting immediately upon release into seawater.
Anti-ABCe was made against the region between TMS 7 and 8. This region
is thought to be a regulatory region in ABCA1 (25), and several models
have been proposed describing the topology of this region in subfamily
A members (24, 30). With ABCA1, data support a model for an
intracellular location with the hydrophobic region (TMS 7) sticking
into the membrane but not passing through it (24). In ABCA4, evidence
indicates that the region corresponding to TMS 7 passes through the
membrane so that the region between TMS 7 and 8 is extracellular. Like
ABCA4, our data support an extracellular location of this region.
Twenty kDa of the relative molecular mass of suABCA can be accounted
for by N-linked glycosylation, and five N-linked
sites are predicted in this region. Two sites are present in the
sequenced peptides, and asparagine residues could not be identified via
Edman degradation, indicating that they are glycosylated. Also the
anti-ABCe antibody made against this putative extracellular region
binds non-permeabilized cells, and the level of binding does not change
after permeabilization. Because this region may be a regulatory in some
ABCA members (25), anti-ABCe was dialyzed into FSW and applied to live
sperm. No differences could be detected in swimming behavior, cell
agglutination, or acrosome reactions (data not shown).
suABCA has a distinct punctate pattern of immunofluorescence. To test
the possibility that suABCA was present in specific membrane
microdomains, anti-ABCe immunoblots were performed on isolated lipid
rafts. Rafts have previously been isolated from sea urchin sperm and
shown to be enriched in glycosphingolipids but not cholesterol (22).
Several sea urchin membrane proteins such as the speract receptor,
suREJ1, adenylate cyclase, and guanylate cyclase have been detected in
the raft fraction but suABCA is not (31). Likewise, human ABCA1 does
not associate with sphingomyelin/cholesterol-rich lipid rafts (32).
Immunofluorescence of testis homogenates shows that the protein is
present in a similar pattern on all immature spermatogenic cells (data
not shown). A potential role for suABCA could be involved in the early
stages of membrane structuring to create the terminally differentiated
mature spermatozoa.
Although many proteins and carbohydrates have been identified as
important players in sperm-egg interactions (4), the membrane alterations during fertilization are poorly understood. One interesting question raised by this work is why suABCA is such an abundant membrane
protein present on the entire surface of the sperm. Sperm might alter
their membranes during spermatogenesis, motility, the acrosome
reaction, and ultimately sperm-egg fusion.
This research has implications beyond sperm physiology. Membrane
vesicles can be isolated from sperm as right-side-out vesicles by the
pH 9 method (33) or as a mixture of right-side-out and inside-out
vesicles by nitrogen cavitation (34). suABCA remains tightly associated
with SMVs. SMV preparations can be combined with methods such as WGA
chromatography or affinity chromatography to enrich for
suABCA-containing lipid vesicles. The abundance of suABCA may offer an
excellent opportunity to study the biochemical properties of these
transporters in their native environment.
 |
ACKNOWLEDGEMENTS |
We thank Yi-Hsien Su and Brian J. Hillier for
providing testis RNA and whole sea urchin cDNA and Anna T. Neill
for reviewing the manuscript.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grant HD12986.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AF529424.
To whom correspondence should be addressed: Center for Marine
Biotechnology and Biomedicine, Scripps Inst. of Oceanography, University of California San Diego, 9500 Gilman Dr., La Jolla, CA
92093-0202. Tel.: 858-534-4803; Fax: 858-534-7313; E-mail: vvacquier@ucsd.edu.
Published, JBC Papers in Press, August 21, 2002, DOI 10.1074/jbc.M207184200
 |
ABBREVIATIONS |
The abbreviations used are:
AR, acrosome
reaction;
ABC, ATP-binding cassette;
ABCA, ABC subfamily A;
ABCe, bacterially expressed protein;
FSW, filtered seawater;
HDL, high
density lipoprotein;
TMS, transmembrane segment(s);
WGA, wheat germ
agglutinin;
NBD, nucleotide-binding domain;
SMV, sperm membrane
vesicle;
PNGase F, protein:N-glycanase F;
PVDF, polyvinylidene difluoride;
PBS, phosphate-buffered saline.
 |
REFERENCES |
| 1.
|
Visconti, P. E.,
Westbrook, V. A.,
Chertihin, O.,
Demarco, I.,
Sleight, S.,
and Diekman, A. B.
(2002)
J. Reprod. Immunol.
53,
133-150[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Bearer, E. L.,
and Friend, D. S.
(1990)
J. Electron Microsc. Technol.
16,
281-297[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Vacquier, V. D.,
and Moy, G. W.
(1997)
Dev. Biol.
192,
125-135[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Mengerink, K. J.,
and Vacquier, V. D.
(2001)
Glycobiology
11,
37R-43R[Abstract/Free Full Text]
|
| 5.
|
Podell, S. B.,
and Vacquier, V. D.
(1984)
J. Cell Biol.
99,
1598-1604[Abstract/Free Full Text]
|
| 6.
|
Moy, G. W.,
Mendoza, L. M.,
Schulz, J. R.,
Swanson, W. J.,
Glabe, C. G.,
and Vacquier, V. D.
(1996)
J. Cell Biol.
133,
809-817[Abstract/Free Full Text]
|
| 7.
|
Mengerink, K. J.,
Moy, G. W.,
and Vacquier, V. D.
(2002)
J. Biol. Chem.
277,
943-948[Abstract/Free Full Text]
|
| 8.
|
Croop, J. M.
(1998)
Methods Enzymol.
292,
101-116[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Klein, I.,
Sarkadi, B.,
and Varadi, A.
(1999)
Biochim. Biophys. Acta
1461,
237-262[Medline]
[Order article via Infotrieve]
|
| 10.
|
Dean, M.,
Hamon, Y.,
and Chimini, G.
(2001)
J. Lipid Res.
42,
1007-1017[Abstract/Free Full Text]
|
| 11.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Altschul, S. F.,
Gish, W.,
Miller, W.,
Myers, E. W.,
and Lipman, D. J.
(1990)
J. Mol. Biol.
215,
403-410[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Nielsen, H.,
Engelbrecht, J.,
Brunak, S.,
and von Heijne, G.
(1997)
Protein Eng.
10,
1-6[Abstract/Free Full Text]
|
| 14.
|
Kyte, J.,
and Doolittle, R. F.
(1982)
J. Mol. Biol.
157,
105-132[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Krogh, A.,
Larsson, B.,
von Heijne, G.,
and Sonnhammer, E. L. L.
(2001)
J. Mol. Biol.
305,
567-580[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Higgins, D. G.,
Thompson, J. D.,
and Gibson, T. J.
(1996)
Methods Enzymol.
266,
383-402[Medline]
[Order article via Infotrieve]
|
| 17.
|
Thompson, J. D.,
Gibson, T. J.,
Plewniak, F.,
Jeanmougin, F.,
and Higgins, D. G.
(1997)
Nucleic Acids Res.
25,
4876-4882[Abstract/Free Full Text]
|
| 18.
|
Nicholas, K. B.,
Nicholas, H. B., Jr.,
and Deerfield, D. W., II
(1997)
EMBNEW News
4,
14
|
| 19.
|
Page, R. D.
(1996)
Comput. Appl. Biosci.
12,
357-358[Free Full Text]
|
| 20.
|
Lee, C.,
Levin, A.,
and Branton, D.
(1987)
Anal. Biochem.
166,
308-312[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Vacquier, V. D.
(1986)
Methods Cell Biol.
27,
15-40[Medline]
[Order article via Infotrieve]
|
| 22.
|
Ohta, K.,
Sato, C.,
Matsuda, T.,
Toriyama, M.,
Lennarz, W. J.,
and Kitajima, K.
(1999)
Biochem. Biophys. Res. Commun.
258,
616-623[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Morrissey, J. H.
(1981)
Anal. Biochem.
117,
307-310[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Schmitz, G.,
and Langmann, T.
(2001)
Curr. Opin. Lipidol.
12,
129-140[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Broccardo, C.,
Luciani, M.-F.,
and Chimini, G.
(1999)
Biochim. Biophys. Acta
1461,
395-404[Medline]
[Order article via Infotrieve]
|
| 26.
|
Mulugeta, S.,
Gray, J. M.,
Notarfrancesco, K. L.,
Gonzales, L. W.,
Koval, M.,
Feinstein, S. I.,
Ballard, P. L.,
Fisher, A. B.,
and Shuman, H.
(2002)
J. Biol. Chem.
277,
22147-22155[Abstract/Free Full Text]
|
| 27.
|
Yamano, G.,
Funahashi, H.,
Kawanami, O.,
Zhao, L. X.,
Ban, N.,
Uchida, Y.,
Morohoshi, T.,
Ogawa, J.,
Shioda, S.,
and Inagaki, N.
(2001)
FEBS Lett.
508,
221-225[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Lin, G.
(2002)
Biochem. Biophys. Res. Commun.
291,
727-731[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Oram, J. F.,
and Lawn, R. M.
(2001)
J. Lipid Res.
42,
1173-1179[Abstract/Free Full Text]
|
| 30.
|
Bungert, S.,
Molday, L. L.,
and Molday, R. S.
(2001)
J. Biol. Chem.
276,
23539-23546[Abstract/Free Full Text]
|
| 31.
|
Ohta, K.,
Sato, C.,
Matsuda, T.,
Toriyama, M.,
Vacquier, V. D.,
Lennarz, W. J.,
and Kitajima, K.
(2000)
Glycoconj. J.
17,
205-214[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Mendez, A. J.,
Lin, G.,
Wade, D. P.,
Lawn, R. M.,
and Oram, J. F.
(2001)
J. Biol. Chem.
276,
3158-3166[Abstract/Free Full Text]
|
| 33.
|
Podell, S. B.,
Moy, G. W.,
and Vacquier, V. D.
(1984)
Biochim. Biophys. Acta
778,
25-37[Medline]
[Order article via Infotrieve]
|
| 34.
|
Ward, G. E.,
Moy, G. W.,
and Vacquier, V. D.
(1986)
J. Cell Biol.
103,
95-101[Abstract/Free Full Text]
|
| 35.
|
Podell, S. B.,
and Vacquier, V. D.
(1985)
J. Biol. Chem.
260,
2715-2718[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|